{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:07:37Z","timestamp":1782842857015,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Characterization of combination effects of chemotherapy drugs with carbon ions in comparison to photons in vitro.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The human colon adenocarcinoma cell line WiDr was tested for combinations with camptothecin, cisplatin, gemcitabine and paclitaxel. In addition three other human tumour cell lines (A549: lung, LN-229: glioblastoma, PANC-1: pancreas) were tested for the combination with camptothecin. Cells were irradiated with photon doses of 2, 4, 6 and 8\u00a0Gy or carbon ion doses of 0.5, 1, 2 and 3\u00a0Gy. Cell survival was assessed using the clonogenic growth assay. Treatment dependent changes in cell cycle distribution (up to 12\u00a0hours post-treatment) were measured by FACS analysis after propidium-iodide staining. Apoptosis was monitored for up to 36\u00a0hours post-treatment by Nicoletti-assay (with qualitative verification using DAPI staining).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All cell lines exhibited the well-known increase of killing efficacy per unit dose of carbon ion exposure, with relative biological efficiencies at 10% survival (RBE<jats:sub>10<\/jats:sub>) ranging from 2.3 to 3.7 for the different cell lines. In combination with chemotherapy additive toxicity was the prevailing effect. Only in combination with gemcitabine or cisplatin (WiDr) or camptothecin (all cell lines) the photon sensitivity was slightly enhanced, whereas purely independent toxicities were found with the carbon ion irradiation, in all cases. Radiation-induced cell cycle changes displayed the generally observed dose-dependent G2-arrest with little effect on S-phase fraction for all cell lines for photons and for carbon ions. Only paclitaxel showed a significant induction of apoptosis in WiDr cell line but independent of the used radiation quality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Combined effects of different chemotherapeutics with photons or with carbon ions do neither display qualitative nor substantial quantitative differences. Small radiosensitizing effects, when observed with photons are decreased with carbon ions. The data support the idea that a radiochemotherapy with common drugs and carbon ion irradiation might be as feasible as respective photon-based protocols. The present data serve as an important radiobiological basis for further combination experiments, as well as clinical studies on combination treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-8-260","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T08:01:44Z","timestamp":1383724904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro"],"prefix":"10.1186","volume":"8","author":[{"given":"Fabian","family":"Schlaich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Brons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Josef","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"980_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0959-8049(01)00363-X","volume":"38","author":"H Bartelink","year":"2002","unstructured":"Bartelink H, Schellens JHM, Verheij M: The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 2002, 38: 216-222. 10.1016\/S0959-8049(01)00363-X","journal-title":"Eur J Cancer"},{"key":"980_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0273-1177(95)00784-C","volume":"18","author":"M Scholz","year":"1996","unstructured":"Scholz M, Kraft G: Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res 1996, 18: 5-14.","journal-title":"Adv Space Res"},{"key":"980_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/153303460300200507","volume":"2","author":"M Kr\u00e4mer","year":"2003","unstructured":"Kr\u00e4mer M, Weyrather WK, Scholz M: The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat 2003, 2: 427-436.","journal-title":"Technol Cancer Res Treat"},{"key":"980_CR4","first-page":"10","volume":"166","author":"G Kraft","year":"1990","unstructured":"Kraft G: The radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther Onkol 1990, 166: 10-13.","journal-title":"Strahlenther Onkol"},{"key":"980_CR5","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.2307\/3579815","volume":"150","author":"EA Blakely","year":"1998","unstructured":"Blakely EA, Kronenberg A: Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat Res 1998, 150: S126-S145. 10.2307\/3579815","journal-title":"Radiat Res"},{"key":"980_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/09553009314551261","volume":"64","author":"KJ Weber","year":"1993","unstructured":"Weber KJ, Flentje M: Lethality of heavy ion-induced DNA double-strand breaks in mammalian cells. Int J Radiat Biol 1993, 64: 169-178. 10.1080\/09553009314551261","journal-title":"Int J Radiat Biol"},{"key":"980_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2011.12.013","volume":"103","author":"J-E Mizoe","year":"2012","unstructured":"Mizoe J-E, Hasegawa A, Jingu K, Takagi R, Bessyo H, Morikawa T, Tonoki M, Tsuji H, Kamada T, Tsujii H, Okamoto Y: Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 2012, 103: 32-37. 10.1016\/j.radonc.2011.12.013","journal-title":"Radiother Oncol"},{"key":"980_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/1471-2407-10-478","volume":"10","author":"SE Combs","year":"2010","unstructured":"Combs SE, Kieser M, Rieken S, Habermehl D, J\u00e4kel O, Haberer T, Nikoghosyan A, Haselmann R, Unterberg A, Wick W, Debus J: Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. BMC Cancer 2010, 10: 478. 10.1186\/1471-2407-10-478","journal-title":"BMC Cancer"},{"key":"980_CR9","first-page":"913","volume":"15","author":"H Kitabayashi","year":"2006","unstructured":"Kitabayashi H, Shimada H, Yamada S, Yasuda S, Kamata T, Ando K, Tsujii H, Ochiai T: Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation. Oncol Rep 2006, 15: 913-918.","journal-title":"Oncol Rep"},{"key":"980_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1748-717X-7-9","volume":"7","author":"SE Combs","year":"2012","unstructured":"Combs SE, Zipp L, Rieken S, Habermehl D, Brons S, Winter M, Haberer T, Debus J, Weber K-J: In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiat Oncol 2012, 7: 9. 10.1186\/1748-717X-7-9","journal-title":"Radiat Oncol"},{"key":"980_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG, Peckham MJ: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979, 5: 85-91.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"980_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1083\/jcb.66.1.188","volume":"66","author":"A Krishan","year":"1975","unstructured":"Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975, 66: 188-193. 10.1083\/jcb.66.1.188","journal-title":"J Cell Biol"},{"key":"980_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139: 271-279. 10.1016\/0022-1759(91)90198-O","journal-title":"J Immunol Methods"},{"key":"980_CR14","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.bmc.2003.11.036","volume":"12","author":"CJ Thomas","year":"2004","unstructured":"Thomas CJ, Rahier NJ, Hecht SM: Camptothecin: current perspectives. Bioorg Med Chem 2004, 12: 1585-1604. 10.1016\/j.bmc.2003.11.036","journal-title":"Bioorg Med Chem"},{"key":"980_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14786410412331299005","volume":"19","author":"D Sriram","year":"2005","unstructured":"Sriram D, Yogeeswari P, Thirumurugan R, Bal TR: Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat Prod Res 2005, 19: 393-412. 10.1080\/14786410412331299005","journal-title":"Nat Prod Res"},{"key":"980_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/cbt.7.3.5363","volume":"7","author":"CS Djuzenova","year":"2008","unstructured":"Djuzenova CS, G\u00fcttler T, Berger S, Katzer A, Flentje M: Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment. Cancer Biol Ther 2008, 7: 364-373. 10.4161\/cbt.7.3.5363","journal-title":"Cancer Biol Ther"},{"key":"980_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00066-002-0959-y","volume":"178","author":"M Rave-Fr\u00e4nk","year":"2002","unstructured":"Rave-Fr\u00e4nk M, Glomme S, Hertig J, Weiss E, Pradier O, Hess CF, Virsik-K\u00f6pp P, Schmidberger H: Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro. Strahlenther Onkol 2002, 178: 497-503. 10.1007\/s00066-002-0959-y","journal-title":"Strahlenther Onkol"},{"key":"980_CR18","first-page":"1663","volume":"10","author":"T Boulikas","year":"2003","unstructured":"Boulikas T, Vougiouka M: Cisplatin and platinum drugs at the molecular level: (Review). Oncol Rep 2003, 10: 1663-1682.","journal-title":"Oncol Rep"},{"key":"980_CR19","first-page":"559","volume":"11","author":"T Boulikas","year":"2004","unstructured":"Boulikas T, Vougiouka M: Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep 2004, 11: 559-595.","journal-title":"Oncol Rep"},{"key":"980_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0167-8140(92)90355-X","volume":"24","author":"M Flentje","year":"1992","unstructured":"Flentje M, Eble M, Haner U, Trinh S, Wannenmacher M: Additive effects of cisplatin and radiation in human tumor cells under oxic conditions. Radiother Oncol 1992, 24: 60-63. 10.1016\/0167-8140(92)90355-X","journal-title":"Radiother Oncol"},{"key":"980_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0304-3835(96)04140-7","volume":"101","author":"AA Geldof","year":"1996","unstructured":"Geldof AA, Slotman BJ: Radiosensitizing effect of cisplatin in prostate cancer cell lines. Cancer Lett 1996, 101: 233-239. 10.1016\/0304-3835(96)04140-7","journal-title":"Cancer Lett"},{"key":"980_CR22","first-page":"505","volume":"19","author":"AA Geldof","year":"1999","unstructured":"Geldof AA, Kruit A, Newling DW, Slotman BJ: Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line. Anticancer Res 1999, 19: 505-508.","journal-title":"Anticancer Res"},{"key":"980_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.radonc.2009.04.019","volume":"92","author":"N Zhang","year":"2009","unstructured":"Zhang N, Erjala K, Kulmala J, Qiu X, Sundvall M, Elenius K, Gr\u00e9nman R: Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro. Radiother Oncol 2009, 92: 388-392. 10.1016\/j.radonc.2009.04.019","journal-title":"Radiother Oncol"},{"key":"980_CR24","first-page":"100","volume-title":"Anticancer therapeutics","author":"J Scaife","year":"2008","unstructured":"Scaife J, Kerr D: Antimetabolites in cancer therapy. In Anticancer therapeutics. Edited by: Missailidis S. Oxford: Wiley-Blackwell; 2008:100-101."},{"key":"980_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0360-3016(98)00105-9","volume":"41","author":"D Latz","year":"1998","unstructured":"Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ: Radiosensitizing potential of gemcitabine (2\u2019,2\u2019-difluoro-2\u2019-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 1998, 41: 875-882. 10.1016\/S0360-3016(98)00105-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"980_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1025513106330","volume":"8","author":"F Mollinedo","year":"2003","unstructured":"Mollinedo F, Gajate C: Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003, 8: 413-450. 10.1023\/A:1025513106330","journal-title":"Apoptosis"},{"key":"980_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004, 4: 253-265. 10.1038\/nrc1317","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 2","key":"980_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.9-suppl_2-3","volume":"9","author":"J Gligorov","year":"2004","unstructured":"Gligorov J, Lotz JP: Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 2004,9(Suppl 2):3-8.","journal-title":"Oncologist"},{"key":"980_CR29","first-page":"3495","volume":"52","author":"RB Tishler","year":"1992","unstructured":"Tishler RB, Geard CR, Hall EJ, Schiff PB: Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992, 52: 3495-3497.","journal-title":"Cancer Res"},{"issue":"Suppl 3","key":"980_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF03215919","volume":"175","author":"F Wenz","year":"1999","unstructured":"Wenz F, Greiner S, Germa F, Mayer K, Latz D, Weber KJ: Radiochemotherapy with paclitaxel: synchronization effects and the role of p53. Strahlenther Onkol 1999,175(Suppl 3):2-6.","journal-title":"Strahlenther Onkol"},{"key":"980_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/09553009414550951","volume":"66","author":"M Scholz","year":"1994","unstructured":"Scholz M, Kraft-Weyrather W, Ritter S, Kraft G: Cell cycle delays induced by heavy ion irradiation of synchronous mammalian cells. Int J Radiat Biol 1994, 66: 59-75. 10.1080\/09553009414550951","journal-title":"Int J Radiat Biol"},{"key":"980_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2307\/3575025","volume":"79","author":"C L\u00fccke-Huhle","year":"1979","unstructured":"L\u00fccke-Huhle C, Blakely EA, Chang PY, Tobias CA: Drastic G2 arrest in mammalian cells after irradiation with heavy-ion beams. Radiat Res 1979, 79: 97-112. 10.2307\/3575025","journal-title":"Radiat Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-8-260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:16:45Z","timestamp":1630549005000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-8-260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-8-260","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,6]]},"assertion":[{"value":"19 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"260"}}